Evidence map›Paper›PMID 41691604›Full record

ArticleThe Journal of physiology2026

Compromised synaptic signal from prefrontal cortex to mediodorsal thalamus in Alzheimer's disease models and its rescue by kinase inhibitors.

Ping Zhong, Tarek Shaker, Pei Li, Zhen Yan

Abstract read
In one paragraph

Article in The Journal of physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ping ZhongDepartment of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.
Tarek ShakerDepartment of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.
Pei LiDepartment of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.
Zhen YanDepartment of Physiology and Biophysics, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York, USA.

Funding

Transcriptomic and Circuitry Aberrations in Alzheimer’s DiseaseR01AG079797 · NIA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI JIAN FENG, Zhen Yan · 2023 to 2026
$3.0M
Targeting Histone K4 Methylation for Treatment of Alzheimer's Disease and Related DementiaR01AG064656 · NIA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI YAN, ZHEN · 2019 to 2023
$2.5M
New Treatment Strategy for Alzheimer’s DiseaseR21AG067597 · NIA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI FENG, JIAN, YAN, ZHEN · 2020 to 2021
$439k
NIA NIH HHS R01 AG064656NIA NIH HHS R01 AG079797NIA NIH HHS R21 AG067597
6 · The paper itself

Abstract

One of the most important neural circuits controlling cognitive processes is the projection from prefrontal cortex (PFC) to thalamus. To determine the strength of PFC projections to different thalamic nuclei, we performed optogenetic experiments by injecting channelrhodopsin-2 (ChR2) to medial PFC and recording synaptic responses evoked by light stimulation of ChR2-expressing terminals in thalamic neurons. The mediodorsal thalamus (MD) had markedly larger synaptic currents than neighbouring areas, suggesting that PFC sends prominent signals to MD. To determine whether the PFC to MD pathway is altered at early stages of Alzheimer's disease (AD), we used two mouse models (∼4 months old), transgenic mice carrying the human P301S mutation of microtubule-associated protein tau (Tau), and familial AD mice carrying five mutations on APP and PS1 (5xFAD). Both AD mouse models exhibited a more significant decline in short-term depression (STD) of synaptic responses in response to repeated light stimulation of MD ChR2 signals. Optogenetic imaging showed that Tau mice had significantly reduced ChR2 expression in MD axon terminals innervated by PFC. Next, we inhibited two kinases, serum and glucocorticoid-regulated kinase 1 (SGK1) and glycogen synthase kinase-3 beta (GSK3β), both of which can induce tau hyperphosphorylation and the ensuing disruption of microtubule-based transport in AD. Treatment with SGK1 or GSK3β inhibitor normalized STD of PFC to MD synaptic responses in Tau mice, but not in 5xFAD mice. These results suggest that the synaptic connectivity in the PFC-to-MD pathway is compromised in AD, which may be due to tau kinase-induced disruption of axonal transport. KEY POINTS: Optogenetic recordings reveal the strong connection from prefrontal cortex (PFC) to mediodorsal thalamus (MD). Short-term depression (STD) of PFC to MD synaptic responses is altered in P301S Tau and 5xFAD mouse models of Alzheimer's disease (AD). Optogenetic imaging uncovers the significantly reduced PFC to MD projection in Tau mice. Inhibition of tau kinase SGK1 or GSK3β normalizes STD of PFC to MD synaptic responses in Tau mice, but not 5xFAD mice. These results suggest that the synaptic information transfer from PFC to MD pathway is compromised in AD, probably via tau kinase-induced disruption of axonal transport.

Indexed as

Alzheimer DiseasePrefrontal CortexProtein Kinase InhibitorsSynapsesAnimalsDisease Models, AnimalGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHumansImmediate-Early ProteinsMaleMiceMice, Inbred C57BLMice, TransgenicOptogeneticsProtein Serine-Threonine KinasesGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGsk3b protein, mouseImmediate-Early ProteinsProtein Kinase InhibitorsProtein Serine-Threonine KinasesSerum-Glucocorticoid Regulated Kinasestau ProteinsAlzheimer's diseaseaxonal transportGSK3βmediodorsal thalamusneural circuitoptogeneticsprefrontal cortexSGK1short‐term depression

Identifiers

PMID41691604
PMCPMC13589833

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.